Maria-Victoria Mateos, MD, PhD | Authors


Key Findings Reviewed From ALCYONE Trial in Myeloma

December 04, 2018

Maria-Victoria Mateos, MD, PhD, discusses the key takeaways from the phase III ALCYONE trial looking at bortezomib, melphalan, and prednisone in combination with daratumumab in patients with newly diagnosed multiple myeloma who are transplant ineligible.